Literature DB >> 34118917

Awareness, knowledge and trust in the Greek authorities towards COVID-19 pandemic: results from the Epirus Health Study cohort.

Afroditi Kanellopoulou1, Fotios Koskeridis1, Georgios Markozannes1, Emmanouil Bouras1,2, Chrysa Soutziou3, Konstantinos Chaliasos1, Michail T Doumas3, Dimitrios E Sigounas3, Vasilios T Tzovaras3, Agapios Panos1, Yiolanda Stergiou1, Kassiani Mellou4, Dimitrios Papamichail5, Eleni Aretouli6,7, Dimitrios Chatzidimitriou8, Fani Chatzopoulou8, Eleni Bairaktari9, Ioanna Tzoulaki1,10, Evangelos Evangelou1,10, Evangelos C Rizos11,12, Evangelia Ntzani1,13,14, Konstantinos Vakalis3, Konstantinos K Tsilidis15,16.   

Abstract

BACKGROUND: To assess the level of knowledge and trust in the policy decisions taken regarding the coronavirus disease (COVID-19) pandemic among Epirus Health Study (EHS) participants.
METHODS: The EHS is an ongoing and deeply-phenotyped prospective cohort study that has recruited 667 participants in northwest Greece until August 31st, 2020. Level of knowledge on coronavirus (SARS-CoV-2) transmission and COVID-19 severity was labeled as poor, moderate or good. Variables assessing knowledge and beliefs towards the pandemic were summarized overall and by sex, age group (25-39, 40-49, 50-59, ≥60 years) and period of report (before the lifting of lockdown measures in Greece: March 30th to May 3rd, and two post-lockdown time periods: May 4th to June 31st, July 1st to August 31st). A hypothesis generating exposure-wide association analysis was conducted to evaluate the associations between 153 agnostically-selected explanatory variables and participants' knowledge. Correction for multiple comparisons was applied using a false discovery rate (FDR) threshold of 5%.
RESULTS: A total of 563 participants (49 years mean age; 60% women) had available information on the standard EHS questionnaire, the clinical and biochemical measurements, and the COVID-19-related questionnaire. Percentages of poor, moderate and good knowledge status regarding COVID-19 were 4.5, 10.0 and 85.6%, respectively. The majority of participants showed absolute or moderate trust in the Greek health authorities for the management of the epidemic (90.1%), as well as in the Greek Government (84.7%) and the official national sources of information (87.4%). Trust in the authorities was weaker in younger participants and those who joined the study after the lifting of lockdown measures (p-value≤0.001). None of the factors examined was associated with participants' level of knowledge after correction for multiple testing.
CONCLUSIONS: High level of knowledge about the COVID-19 pandemic and trust in the Greek authorities was observed, possibly due to the plethora of good quality publicly available information and the timely management of the pandemic at its early stages in Greece. Information campaigns for the COVID-19 pandemic should be encouraged even after the lifting of lockdown measures to increase public awareness.

Entities:  

Keywords:  COVID-19; Cohort study; Epirus health study; Exposure-wide association analysis; Knowledge; Trust in authorities

Year:  2021        PMID: 34118917     DOI: 10.1186/s12889-021-11193-x

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  13 in total

1.  The verbal fluency task in the Greek population: normative data, and clustering and switching strategies.

Authors:  Mary H Kosmidis; Christina H Vlahou; Panagiota Panagiotaki; Grigorios Kiosseoglou
Journal:  J Int Neuropsychol Soc       Date:  2004-03       Impact factor: 2.892

2.  Evaluation of the Mobil-O-Graph new generation ABPM device using the ESH criteria.

Authors:  Pascal M L Franssen; Ben P M Imholz
Journal:  Blood Press Monit       Date:  2010-08       Impact factor: 1.444

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Compendium of physical activities: classification of energy costs of human physical activities.

Authors:  B E Ainsworth; W L Haskell; A S Leon; D R Jacobs; H J Montoye; J F Sallis; R S Paffenbarger
Journal:  Med Sci Sports Exerc       Date:  1993-01       Impact factor: 5.411

5.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

6.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

7.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 8.  Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.

Authors:  Jia Liu; Xin Zheng; Qiaoxia Tong; Wei Li; Baoju Wang; Kathrin Sutter; Mirko Trilling; Mengji Lu; Ulf Dittmer; Dongliang Yang
Journal:  J Med Virol       Date:  2020-02-21       Impact factor: 2.327

9.  Coronavirus (COVID-19) in Italy: knowledge, management of patients and clinical experience of Italian dentists during the spread of contagion.

Authors:  Alessandra Putrino; Mario Raso; Cosimo Magazzino; Gabriella Galluccio
Journal:  BMC Oral Health       Date:  2020-07-10       Impact factor: 2.757

10.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.